BDO’s Health & Life Sciences Rx Podcast, hosted by The BDO Center for Healthcare Excellence & Innovation and the Life Sciences practice, seeks to provide insights into the trends disrupting healthcare and how companies can adapt and evolve in an ever-changing business landscape.
The drug development process is costly, time consuming and laden with risk—with only 1% of drugs making it from pre-clinical all the way to market, according to Pharma Intelligence. To beat these odds, life sciences leaders must know when to continue funding a promising, new product and when to call it quits.
Tune in for insights into:
Tune in for insights on:
Seniors—the fastest-growing U.S. age demographic—are poised to make up more than 20 percent of the U.S. population by 2029. And they’re moving to the driver’s seat of care. Now, they’re demanding elder care more rooted in empathy and designed on their own terms—and in their preferred environment. With these shifts, new types of entities—including those building alternative types of senior care communities—will form, and health organizations will need to create and fill new types of roles.
With KKR's $10 billion purchase of Envision Healthcare this summer, the largest healthcare buyout deal since the financial crisis, private equity's appetite for healthcare deals might well be stronger than ever. Meanwhile, with Amazon's emerging healthcare arm and an imminent deal between CVS and Aetna, providers are turning to digital innovation to help navigate industry disruption.
Tune into the full episode for a range of insights, including:
Tune in to the full episode to hear about:
Tune in to the full episode to hear about: